Oragenics, Inc. (OGEN) Return on equity 2016–2024
Oragenics, Inc. (OGEN) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-33356.7%FY2024 · since FY2016: -148.2% → -33356.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -33356.7% | -33197.9 pp |
| FY2023 | -158.8% | -104.8 pp |
| FY2022 | -53.9% | — |
| FY2018 | -157.0% | +70.0 pp |
| FY2017 | -227.0% | -78.7 pp |
| FY2016 | -148.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice